Skip to main content
 

Microgen Biotech raises $3.8m in Series A funding round

MicroGen Biotech has raised $3.8M Series A financing from US and European Agtech investors. The funding was led by Fulcrum Global Capital with participation from The Yield Lab Europe.

MicroGen Biotech  provides a patented, cost effective, safe and scalable solution to reduce heavy metal in food, increase soil health to enhance crop yields and clean soil pollution in industrial sites.

Heavy metal content in foods has emerged as a global issue, caused by industrial pollution, and crop inputs. Rice, wheat, cocoa, and leafy greens take up heavy metal residues and concentrate them in our food, which then accumulate in the human body.  Ingestion of heavy metals causes toxic and carcinogenic effects especially in infants. Up to 95% of baby food contain toxic heavy metals.

MicroGen Biotech has successfully registered two products with the Chinese Ministry of Agriculture following extensive field trials, covering 20,000 acres, and is rolling out its products nationwide. In the USA, it has partnered a leading agricultural input company to develop a low-arsenic rice solution for North America. 

Rapid Innovation has worked with Microgen biotech since 2017.

Find out more here